Sanofi, Amgen see competing claims over PCSK9 patent both dismissed by UPC
MLex Summary: Both French drugmaker Sanofi's infringement action and US rival Amgen 's counterclaim for revocation regarding European patent 3,536,712 B1 have been dismissed by the Unified Patent Court’s Düsseldorf Local...To view the full article, register now.
Already a subscriber? Click here to view full article